Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-seq profiles of primary, metastatic, drug-resistant and drug-holiday cells

ABSTRACT: ChIP-seq profiles of primary, metastatic, drug-resistant and drug-holiday cells

PROVIDER: PRJNA493811 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7941340.fastq.gz	Fastqsanger.gz
	SRR7941341.fastq.gz	Fastqsanger.gz
	SRR7941332.fastq.gz	Fastqsanger.gz
	SRR7941342.fastq.gz	Fastqsanger.gz
	SRR7941333.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 17

Similar Datasets

Single cell RNA-seq profiles of primary, metastatic, drug-resistant and drug-holiday cells

Project description:Single cell RNA-seq profiles of primary, metastatic, drug-resistant and drug-holiday cells

| PRJNA483471 | ENA

Single cell RNA-seq profiles of primary, metastatic, drug-resistant and drug-holiday cells

Project description:We employed Single cell RNA-seq to identify the transcriptome of cisplatin sensitive, resistant and drug-holiday cells from patient-derived OSCC cells isolated from primary and metastatic sites.

2018-11-22 | GSE117872 | GEO

ChIP-seq profiles of primary, metastatic, drug-resistant and drug-holiday cells

Project description:We employed ChIP-seq to detect poised and active chromatin regions in cisplatin sensitive and resistant head neck squamous cell carcinoma patient derived primary and lymph node cell lines.

2018-11-22 | GSE120634 | GEO

miRNA sequence analysis of drug-resistant small cell lung cancer

Project description:We obtained small cell lung cancer specimens and normal lung specimens from patients who died of drug-resistant SCLC. The small lung cancer specimens include primary lesions and metastatic lesions. Next generation sequencing was performed to assess the expression of miRNA in drug-resistant small cell lung cancer.

2021-06-05 | GSE176198 | GEO

Transcription profiling of human TRAIL-resistant metastatic vs primary TRAIL-sensitive melanoma cells

Project description:T1 and G1 are the two melanoma cell lines, established from primary tumor (T1) and lymph node metastases (G1) of a 77 years old male patient. While G1 cells were resistant to TRAIL (TNF-related apoptosis-inducing ligand) mediated cell death, T1 cells exhibited a high dose- and time-dependent sensitivity to TRAIL. Cells were treated with or without of two doses (0.2 and 1ug/ml) of TRAIL for 24 h. Gene expression of each sample vs pool was measured. TRAIL-resistant metastatic G1 vs primary TRAIL-sensitive T1 was compared.

2006-01-01 | E-MEXP-247 | biostudies-arrayexpress

Heterogeneous therapy-resistant cancer cells have distinct and exploitable drug sensitivity profiles

Project description:Resistance to targeted therapies is a significant clinical problem, but eliminating resistant cancer cells has proven difficult. One potential reason for this difficulty is heterogeneity in the resistant population: even genetically homogeneous cancer cell populations can give rise to many resistant subtypes, each potentially with specific second-line drug vulnerabilities. Using high-throughput drug screening of clonally-derived resistant clones with varying transcriptomes and morphologies, we show that each clone had a distinct drug sensitivity profile. These results suggested that there are drugs that are effective against only subsets of resistant populations but in combination eliminate a large proportion of the resistant population. Using the individual clone sensitivity profiles, we prospectively identified combinations that were highly effective at eliminating most of the resistant population. Our results demonstrate the effectiveness of “subpopulation-directed synergy”, showing that considering population heterogeneity can reveal therapeutic opportunities otherwise masked by population averages, offering new strategies to combat therapy resistance.

2025-11-24 | GSE310838 | GEO

RNA expression profiles of drug-resistant TNBC cell lines after chemotherapy

Project description:RNA expression profiles of drug-resistant TNBC cell lines after chemotherapy

| PRJNA958171 | ENA

Expression Profiles of miRNAs in Drug-Resistant Non-small Cell Lung Cancer Cell Lines Using Next Generation Sequencing

Project description:The expression profiles of miRNAs in drug-resistant non-small cell lung cancer (NSCLC) cell lines were identified via next generation sequencing and the common dysregulated miRNAs in drug-resistant NSCLC cell lines were picked up for further analysis.

2020-11-01 | GSE122452 | GEO

Heterogeneous therapy-resistant cancer cells have distinct and exploitable drug sensitivity profiles

Project description:Heterogeneous therapy-resistant cancer cells have distinct and exploitable drug sensitivity profiles

| PRJNA1367137 | ENA

Expression data of BRAF inhibitor resistant melanoma cells

Project description:We generated four drug-resistant melanoma cell lines from paired primary/metastatic cell lines using PLX4720 and used for Affymetrix Human Gene 1.0 ST array

2019-01-31 | GSE114443 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data